financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Hold Opinion On Shares Of S&p Global Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Hold Opinion On Shares Of S&p Global Inc.
Apr 28, 2026 8:20 AM

10:50 AM EDT, 04/28/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target price by $35 to $500, on a forward P/E of 22.7x our 2027 earnings estimate, a premium to the peer average of 20.8x given greater earnings stability. We increase our 2026 EPS estimate by $0.19 to $19.70 and raise 2027's by $0.06 to $22.05. We view Q1 results as a modest net positive. On the upside, SPGI's core Ratings division accelerated its revenue growth, and the company benefited from AI-fueled infrastructure spending as investment-grade issuance increased due to hyperscaler investments in AI data centers. However, SPGI maintained unchanged 2026 revenue and EPS guidance despite the strong Q1 performance, which was disappointing. Additionally, AI disruption concerns continue to weigh on the stock's valuation multiple. On a positive note, the company's portfolio simplification is progressing as SPGI announced the sale of its geoscience and petroleum engineering software assets within the Energy division, while the Mobility divestiture remains on track for mid-2026.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Boston Scientific Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Boston Scientific Corporation
Mar 11, 2024
01:05 PM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target price on shares of Boston Scientific ( BSX ) to $75 from $71, 29.3x our 2025 EPS estimate, a premium to BSX's historical forward average, justified...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Consolidated Communications Holdings
Research Alert: CFRA Maintains Hold Opinion On Shares Of Consolidated Communications Holdings
Mar 11, 2024
12:10 PM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $5, applying an EV/sales multiple of 2.8x to our 2024 estimate, in line with its 10-year historical average multiple at 2.8x, reflecting our...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Docusign, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Docusign, Inc.
Mar 11, 2024
10:45 AM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $5 to $65, applying an EV/sales multiple of 4.2x to our FY 2025 (Jan.) estimate, a slight premium to peers, reflecting its dominant...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ciena Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ciena Corporation
Mar 11, 2024
10:50 AM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $5 to $55, 24.0x our FY 2024 (Oct.) EPS estimate, a discount to its three-year historical average P/E multiple of 28.1x, reflecting our...
Copyright 2023-2026 - www.financetom.com All Rights Reserved